Latest Market Growth News

Tabcorp Holdings delivered a robust FY25 performance, with revenue and earnings surging thanks to a new Victorian wagering licence and disciplined cost management. The company’s strategic shift towards omnichannel offerings underpins its optimistic outlook for FY26.

AnteoTech Ltd reported a 110% revenue increase to A$968,878 in FY2025 alongside a 24% reduction in net loss, driven by strategic cost savings and key partnerships. Leadership renewal and product validation position the company for growth in battery and life sciences markets.

Paragon Care Limited reported solid FY25 results with revenue climbing to $3.61 billion and underlying EBITDA rising 3%, driven by successful integration and expansion into new healthcare segments.

Wagners Holding Company Limited reported a solid FY25 with revenue of $431.3 million, driven by growth in construction materials and composite fibre technologies, while reducing net debt by 29%.

CleanSpace Holdings posted a robust 26% revenue increase in FY25, turning the corner to positive EBITDA and cash flow in the second half, driven by strong industrial market demand and operational efficiencies.

Centrepoint Alliance has reported a robust FY25 financial performance, surpassing earnings guidance with a 16% rise in EBITDA and a 30% jump in pre-tax profits. The company also declared a 1.75 cent final dividend and advanced its technology and advisory services.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

EVT Limited reported solid full-year FY25 results with revenue and profit growth, driven by record hotel performance and a recovering entertainment division. The group signals confidence with a strong dividend and optimistic FY26 outlook.

X2M Connect has successfully completed an oversubscribed capital raise, securing $5.4 million to strengthen its balance sheet and accelerate growth across Asia and the Middle East.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

Zip Co Limited reported a robust FY25 with revenue up 23.5% to $1.07 billion and cash earnings soaring 147%, driven by strong US market expansion and operational efficiencies.